Literature DB >> 2562831

Insulin-receptor and apolipoprotein genes contribute to development of NIDDM in Chinese Americans.

K S Xiang1, N J Cox, N Sanz, P Huang, J H Karam, G I Bell.   

Abstract

The frequencies of restriction-fragment-length polymorphism (RFLP) alleles as well as RFLP haplotypes at six genetic loci responsible for carbohydrate and lipid metabolism [insulin/insulin-like growth factor II complex, insulin receptor (INSR), HepG2/erythrocyte-type glucose transporter, apolipoprotein A-II, apolipoprotein B (APOB), and the apolipoprotein A-I/C-III/A-IV cluster (APOA1/C3/A4)] were compared between nondiabetic and diabetic Chinese Americans. The disease-association data suggest that genetic variation at the INSR, APOB, and APOA1/C3/A4 loci contributes to the development of non-insulin-dependent diabetes mellitus (NIDDM). The analysis of the INSR locus revealed "protective" haplotypes, and it may be possible to use two of the INSR haplotypes as genetic markers to identify individuals having a very low probability of developing NIDDM regardless of the presence of other genes conferring susceptibility to this disorder. The APOB and APOA1/C3/A4 loci appear to contribute to the development of NIDDM in individuals who are of lean/normal weight and overweight, respectively. The APOA1/C3/A4 locus may account for approximately 8% of the difference between baseline and total possible risk of NIDDM in overweight individuals.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2562831     DOI: 10.2337/diab.38.1.17

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

1.  Screening for insulin receptor gene DNA polymorphisms associated with glucose intolerance in a Scandinavian population.

Authors:  M Sten-Linder; S Vilhelmsdotter; A Wedell; I Stern; T Pollare; P Arner; S Efendić; R Luft; H Luthman
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

2.  Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations.

Authors:  A E Pontiroli; F Capra; F Veglia; M Ferrari; K S Xiang; G I Bell; M G Baroni; D J Galton; J U Weaver; G A Hitman; P G Kopelman; V Mohan; M Viswanathan
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

3.  Non-insulin dependent diabetes and ischaemic heart disease.

Authors:  R J Jarret
Journal:  BMJ       Date:  1989-05-13

4.  Linkage studies of maturity onset diabetes of the young--R.W. pedigree.

Authors:  A J Vinik; N J Cox; K Xiang; S S Fajans; G I Bell
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

5.  Genetic variation in insulin receptor beta-chain exons among members of familial type 2 (non-insulin-dependent) diabetic pedigrees.

Authors:  S C Elbein; L K Sorensen
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

6.  DNA haplotype analysis suggests linkage disequilibrium in the human insulin receptor gene.

Authors:  M Sten-Linder; M Olsson; L Iselius; S Efendić; H Luthman
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

Review 7.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

8.  Insulin receptor gene polymorphisms in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  R S Oelbaum; P M Bouloux; S R Li; M G Baroni; J Stocks; D J Galton
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

9.  Linkage disequilibrium among RFLPs at the insulin-receptor locus despite intervening Alu repeat sequences.

Authors:  S C Elbein
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

10.  DNA polymorphisms in the human tyrosine hydroxylase/insulin/insulin-like growth factor II chromosomal region in relation to glucose and insulin responses.

Authors:  M Sten-Linder; A Wedell; L Iselius; S Efendic; R Luft; H Luthman
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.